# Boxer Derek Chisora Discusses Cannabis for Chronic Pain Management

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/cannabis-pain-management-athletes-chronic-pain-relief/
> **Published:** 2026-05-25T14:08:31-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:54:02-04:00
> **Clinical Summary:** Explore cannabis pain management athletes use for chronic pain relief, focusing on evidence and athlete experiences like Derek Chisora's.

---

✦ New

CED Clinical Relevance
#65
Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.

PainMental HealthIndustryResearchPolicySafetyAnxiety

Why This Matters
Clinicians treating athletes and patients with chronic pain conditions should understand that cannabis may be a patient-reported option for pain management, though evidence remains limited for specific conditions like post-traumatic musculoskeletal pain. Patient testimonials like Chisora’s can inform discussions about cannabis’ role in a comprehensive pain management strategy, but clinicians need robust clinical trial data to make evidence-based recommendations rather than relying on anecdotal reports. As more patients seek cannabis for chronic pain, clinicians should stay informed about efficacy, drug interactions, and regulatory status in their jurisdiction to provide appropriate counseling and monitoring.

Clinical Summary

This article reports on a professional boxer’s anecdotal account of using medical cannabis to manage chronic pain resulting from repeated head trauma and injuries sustained over a 50-fight career, highlighting the growing interest in cannabis as an alternative to opioid-based pain management in athletes and combat sports. While individual testimonials can raise awareness about potential therapeutic applications, they do not constitute clinical evidence and should be distinguished from rigorously controlled research demonstrating efficacy and safety in specific pain conditions. The piece appears alongside coverage of policy initiatives such as Oliver’s Law, which seeks to expand medical cannabis prescribing options for psychiatric conditions, reflecting broader regulatory momentum toward [cannabis legalization](https://cedclinic.com/the-forgotten-history-of-hemp-in-america/) in medical contexts. For clinicians, such high-profile endorsements may increase patient inquiries about [cannabis for pain management](https://cedclinic.com/medical-cannabis-patient-benefits/), necessitating evidence-based discussions about current clinical data, potential risks including cognitive effects relevant to athletes, and established pain management alternatives. Clinicians should counsel patients that while preliminary research suggests cannabis may have analgesic properties, robust [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) comparing cannabis to conventional treatments for post-traumatic or chronic pain in athletic populations remain limited. When patients cite celebrity or athlete use cases, physicians should acknowledge their concerns while emphasizing the importance of evidence-based treatment selection and appropriate monitoring if cannabis is considered.

Dr. Caplan’s Take
“When patients with chronic pain from repetitive trauma come to me after exhausting conventional options, cannabis can be a legitimate tool, but we need honest conversations about efficacy, dosing, and the specific cannabinoid profiles that actually work rather than relying on anecdotal reports from athletes or blanket recommendations.”

Clinical Perspective

While anecdotal reports from public figures like Derek Chisora highlighting cannabis use for [chronic pain management](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/) after repeated head trauma merit attention, such testimonials cannot substitute for rigorous clinical evidence and individual risk-benefit assessment. The neurobiological effects of cannabis on pain perception and inflammation are plausible, yet the evidence base remains limited by small trial sizes, heterogeneous dosing regimens, and insufficient long-term safety data, particularly concerning cognitive effects in patients with a history of traumatic brain injury. Providers should recognize that professional athletes and other individuals with high pain burdens may have different risk tolerances or access to monitoring than typical patients, and extrapolation to general populations requires caution. A pragmatic clinical approach involves documenting patient interest in cannabis for pain, discussing the limited but emerging evidence, screening for contraindications and drug interactions, and considering it as an adjunctive option only after conventional analgesics have been optimized and when

💬 Join the Conversation

Have a question about how this applies to your situation?
[Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers?
[Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/pain-management/)

Have thoughts on this? Share it:

[X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Boxer%20Derek%20Chisora%20Says%20Medical%20Cannabis%20Helps%20Combat%20Chronic%20Pain%20After%2050%20Fights%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D56500)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D56500)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Boxer%20Derek%20Chisora%20Says%20Medical%20Cannabis%20Helps%20Combat%20Chronic%20Pain%20After%2050%20Fights%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D56500)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/)

Related Articles

- [Former Boxer Derek Chisora Advocates for Medical Cannabis Access to Manage Chronic Pain](https://cedclinic.com/former-boxer-derek-chisora-advocates-for-medical-cannabis-access-to-manage-chronic-pain/)

📰 Source: [https://cannabishealthnews.co.uk/2026/05/25/boxer-derek-chisora-says-medical-cannabis-helps-combat-chronic-pain/](https://cannabishealthnews.co.uk/2026/05/25/boxer-derek-chisora-says-medical-cannabis-helps-combat-chronic-pain/)

Further Reading
Cannabis Policy Wire[Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I](https://cedclinic.com/mdmb-4en-pinaca-schedule-i-placement/)
CED Clinic Blog[Fear of recurrence, secondary cancers, and health problems in long-term survivors of childhood cancer: Findings from a Canadian cohort.](https://cedclinic.com/fear-of-recurrence-secondary-cancers-and-health-problems-in-long-term-survi/)
CED Clinic Blog[Associations of cannabis use, other substances, and lifestyle choices on anxiety in medical cannabis patients across 45 days.](https://cedclinic.com/associations-of-cannabis-use-other-substances-and-lifestyle-choices-on-anxi/)

[https://cedclinic.com/contact/](https://cedclinic.com/contact/)

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

[Leave a Message](https://cedclinic.com/contact/)
[Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
[Medical Consulting](https://cedclinic.com/book/)
[Cannabis Care](https://cedclinic.com/book/)

[https://cedclinic.com/contact/](https://cedclinic.com/contact/)

RELATED READING AT CED CLINIC

Continue exploring the evidence

[Former Boxer Derek Chisora Advocates for Medical Cannabis Access to Manage Chronic Pain](https://cedclinic.com/former-boxer-derek-chisora-advocates-for-medical-cannabis-access-to-manage-chronic-pain/)

Learn how Derek Chisora supports medical cannabis access for managing chronic pain after a demanding boxing career.

[Read More](https://cedclinic.com/former-boxer-derek-chisora-advocates-for-medical-cannabis-access-to-manage-chronic-pain/)

[The Evolving Clinical Efficacy of Cannabidiol for Chronic Pain and Patient Access in Australia](https://cedclinic.com/the-evolving-clinical-efficacy-of-cannabidiol-for-chronic-pain-and-patient-access-in-australia/)

Explore recent clinical findings on cannabidiol’s role in [chronic pain management](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/) and patient access developments.

[Explore Insights](https://cedclinic.com/the-evolving-clinical-efficacy-of-cannabidiol-for-chronic-pain-and-patient-access-in-australia/)

[Some Cannabis Types Are Safer Than Others. What Experts Recommend.](https://cedclinic.com/some-cannabis-types-are-safer-than-others-what-experts-recommend/)

Discover expert recommendations on safer cannabis types for therapeutic use, including pain management.

[Learn More](https://cedclinic.com/some-cannabis-types-are-safer-than-others-what-experts-recommend/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
